ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,071,000 | -97.8% | 1,726,019 | -81.6% | 0.06% | -96.0% |
Q1 2021 | $92,347,000 | -10.3% | 9,365,833 | -1.4% | 1.39% | -3.3% |
Q4 2020 | $103,006,000 | +6.3% | 9,502,383 | +1.0% | 1.44% | -18.8% |
Q3 2020 | $96,932,000 | -40.5% | 9,410,860 | +20.6% | 1.77% | -44.1% |
Q2 2020 | $162,898,000 | +129.3% | 7,801,641 | +7.3% | 3.17% | +41.4% |
Q1 2020 | $71,054,000 | – | 7,272,714 | – | 2.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |